bioMerieux's total assets for Q2 2025 were €5.37B, a decrease of -7.00% from the previous quarter. FR:BIM total liabilities were €1.43B for the fiscal quarter, a -8.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.